Clinical Trial Update: Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating efficacy, safety and tolerability of a Pfizer-sponsored treatment in Parkinson's disease; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Pfizer | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED